198 related articles for article (PubMed ID: 22466942)
1. A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula.
Lu CJ; Xiang Y; Xie XL; Xuan ML; He ZH
Chin J Integr Med; 2012 Mar; 18(3):186-91. PubMed ID: 22466942
[TBL] [Abstract][Full Text] [Related]
2. Comparison of PSORI-CM01 granules and Yinxieling tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial.
Yao DN; Lu CJ; Wen ZH; Yan YH; Lu LM; Wu HM; He ZY; Deng H; Deng JW
Ann Palliat Med; 2021 Feb; 10(2):2036-2047. PubMed ID: 33549019
[TBL] [Abstract][Full Text] [Related]
3. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Psoriasis Vulgaris with Medicated Thread Moxibustion of Zhuang Medicine: A Multicenter Randomized, Parallel Controlled Trial.
Pang YZ; Tang J; Zhang QH; Liang FZ; Fang G; Zhao C; Shang HC; Wang LY; Wang YP
Chin J Integr Med; 2022 Mar; 28(3):208-214. PubMed ID: 34897593
[TBL] [Abstract][Full Text] [Related]
5. Effect of Yinxieling decoction on PASI, TNF-α and IL-8 in patients with psoriasis vulgaris.
Dai YJ; Li YY; Zeng HM; Liang XA; Xie ZJ; Zheng ZA; Pan QH; Xing YX
Asian Pac J Trop Med; 2014 Aug; 7(8):668-670. PubMed ID: 25149384
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial.
Li N; Zhao W; Xing J; Liu J; Zhang G; Zhang Y; Li Y; Liu W; Shi F; Bai Y
BMC Complement Altern Med; 2017 May; 17(1):264. PubMed ID: 28506228
[TBL] [Abstract][Full Text] [Related]
7. Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial.
Deng J; Yao D; Lu C; Wen Z; Yan Y; He Z; Wu H; Deng H
BMJ Open; 2017 Nov; 7(11):e014475. PubMed ID: 29101128
[TBL] [Abstract][Full Text] [Related]
8. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
9. Application of metabolomics on diagnosis and treatment of patients with psoriasis in traditional Chinese medicine.
Lu C; Deng J; Li L; Wang D; Li G
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):280-8. PubMed ID: 23747921
[TBL] [Abstract][Full Text] [Related]
10. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of flesh-moistening paste in psoriasis vulgaris patients with symptom pattern of blood stasis: a randomized and parallel-controlled trial.
Guo X; Lang N; Li G; Li P; Qu J; Zhou D; Wang P; Cang Z; Deng B; Lou W; Xu J; Lan H; Liu Y; Zhang W; Sun L
J Tradit Chin Med; 2020 Dec; 40(6):1018-1025. PubMed ID: 33258354
[TBL] [Abstract][Full Text] [Related]
12. Add-on effects of Chinese herbal medicine external application (FZHFZY) to topical urea for mild-to-moderate psoriasis vulgaris: Protocol for a double-blinded randomized controlled pilot trial embedded with a qualitative study.
Wang J; Zhang CS; Zhang AL; Yu J; Deng H; Chen H; Xue CC; Lu C
PLoS One; 2024; 19(3):e0297834. PubMed ID: 38512933
[TBL] [Abstract][Full Text] [Related]
13. To explore the clinical efficacy of Traditional Chinese Medicine bath in the treatment of psoriasis vulgaris with blood-heat syndrome and its effect on related cytokines based on different temperature and different concentration.
Lin W; Yu Q; Qin Y; Dai L; Xiao J; Jiao L; Liu S; Ye S; Zhang J; Chen M
Medicine (Baltimore); 2020 May; 99(19):e20172. PubMed ID: 32384509
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
Menter A; Gordon K; Carey W; Hamilton T; Glazer S; Caro I; Li N; Gulliver W
Arch Dermatol; 2005 Jan; 141(1):31-8. PubMed ID: 15655139
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial.
Lajevardi V; Hallaji Z; Daklan S; Abedini R; Goodarzi A; Abdolreza M
Int J Dermatol; 2015 Jan; 54(1):95-101. PubMed ID: 25209868
[TBL] [Abstract][Full Text] [Related]
16. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
[TBL] [Abstract][Full Text] [Related]
17. Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy.
Wang W; Liu L; Yang Z; Lu C; Tu P; Zhao R; Zeng K
Chin J Nat Med; 2024 Feb; 22(2):127-136. PubMed ID: 38342565
[TBL] [Abstract][Full Text] [Related]
18. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
[TBL] [Abstract][Full Text] [Related]
19. Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.
Parker S; Zhang AL; Zhang CS; Goodman G; Wen Z; Lu C; Xue CC
Trials; 2014 Dec; 15():495. PubMed ID: 25526951
[TBL] [Abstract][Full Text] [Related]
20. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
van de Kerkhof PCM; Loewe R; Mrowietz U; Falques M; Pau-Charles I; Szepietowski JC
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):119-126. PubMed ID: 31465585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
